120 related articles for article (PubMed ID: 15111761)
1. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?
Dabrosin C; Johansson AC; Ollinger K
Breast Cancer Res Treat; 2004 Jun; 85(3):229-38. PubMed ID: 15111761
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin S; Dabrosin C
Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
4. Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
Bannoud N; Carvelli FL; Troncoso M; Sartor T; Vargas-Roig LM; Sosa M
PLoS One; 2018; 13(8):e0201844. PubMed ID: 30086159
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
[TBL] [Abstract][Full Text] [Related]
6. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
7. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
8. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
Nilsson UW; Dabrosin C
Cancer Res; 2006 May; 66(9):4789-94. PubMed ID: 16651433
[TBL] [Abstract][Full Text] [Related]
9. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
10. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
11. Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors.
Zhao Y; Escot C; Maudelonde T; Puech C; Rouanet P; Rochefort H
Cancer Res; 1993 Jun; 53(12):2901-5. PubMed ID: 7684951
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
13. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
14. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.
Capony F; Braulke T; Rougeot C; Roux S; Montcourrier P; Rochefort H
Exp Cell Res; 1994 Nov; 215(1):154-63. PubMed ID: 7957663
[TBL] [Abstract][Full Text] [Related]
15. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Osipo C; Gajdos C; Cheng D; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
[TBL] [Abstract][Full Text] [Related]
16. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
Couissi D; Dubois V; Remacle C; Schonne E; Trouet A
Clin Exp Metastasis; 1997 Jul; 15(4):349-60. PubMed ID: 9219723
[TBL] [Abstract][Full Text] [Related]
17. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
Mathieu M; Vignon F; Capony F; Rochefort H
Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
[TBL] [Abstract][Full Text] [Related]
18. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
Nilsson UW; Jönsson JA; Dabrosin C
Exp Cell Res; 2009 Jan; 315(1):1-9. PubMed ID: 18996114
[TBL] [Abstract][Full Text] [Related]
20. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]